Risperidone Augmentation for PTSD

Clinical trial NCT00215241 · COMPLETED

Trial details

NCT number: NCT00215241
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Post-Traumatic Stress Disorder

Start date: 2004-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.